Susquehanna International Group’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$503K Buy
220,569
+153,514
+229% +$350K ﹤0.01% 4314
2025
Q1
$104K Sell
67,055
-3,836
-5% -$5.95K ﹤0.01% 5846
2024
Q4
$167K Buy
70,891
+50,187
+242% +$118K ﹤0.01% 5427
2024
Q3
$75.2K Buy
20,704
+301
+1% +$1.09K ﹤0.01% 5196
2024
Q2
$71K Sell
20,403
-50,816
-71% -$177K ﹤0.01% 5193
2024
Q1
$454K Buy
71,219
+18,215
+34% +$116K ﹤0.01% 3654
2023
Q4
$341K Buy
+53,004
New +$341K ﹤0.01% 4375
2023
Q3
Hold
0
5555
2023
Q2
Sell
-38,947
Closed -$71.7K 5645
2023
Q1
$71.7K Buy
38,947
+18,744
+93% +$34.5K ﹤0.01% 5358
2022
Q4
$38.4K Buy
20,203
+8,063
+66% +$15.3K ﹤0.01% 5237
2022
Q3
$26K Sell
12,140
-4,477
-27% -$9.59K ﹤0.01% 5663
2022
Q2
$47K Buy
+16,617
New +$47K ﹤0.01% 5246
2022
Q1
Sell
-15,670
Closed -$81K 5725
2021
Q4
$81K Buy
+15,670
New +$81K ﹤0.01% 5351
2021
Q3
Hold
0
5327